DEAL DETAILS |
Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenmark Pharmaceuticals Limited |
NO |
HEADINGS |
DETAILS |
1. |
Sector |
Pharmaceutical Industry |
2. |
Announcement Date |
17-Jan-2023 |
3. |
Completion Date |
17-Jan-2023 |
4. |
Name of Client |
Eris Lifesciences Limited Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company with a pure-play domestic branded formulations business model. Eris has established a leading presence in its core cardio-metabolic franchise in just 15 years from inception. Eris is also successfully diversifying its business with 3 emerging therapies (Dermatology, Neuropsychiatry and Gynaecology). |
5. |
Buyer Details |
Eris Oaknet Healthcare Private Limited | India |
6. |
Seller Details |
Glenmark Pharmaceuticals Limited | India |
7. |
Deal Description |
Eris Oaknet Healthcare Private Limited (a wholly owned subsidiary of the listed entity, Eris Lifesciences Limited) acquired a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited by way of acquisition of 9 (Nine) trademarks along with their applicable line extensions. Eris Oaknet Healthcare Private Limited is the entity which focuses on the dermatology segment business of the listed entity. This transaction helps augment and expand the business of Eris Oaknet Healthcare Private Limited by way of expansion in product offerings |
8. |
Total Consideration |
INR 340 crore (USD 42 million) |
9. |
Team Members |
The core team consisted of Kalpana Unadkat (Partner), Aman Anand (Senior Associate), Ahaan Dar (Associate) with assistance from the following:Arindam Ghosh (Partner), Shailendra Bhandare (Partner) |
10. |
Role of Firm |
Khaitan & Co. advised Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited by way of acquisition of 9 (Nine) trademarks along with their applicable line extensions. |
- Click to share on Facebook (Opens in new window)
- Click to share on Twitter (Opens in new window)
- Click to share on LinkedIn (Opens in new window)
- Click to share on WhatsApp (Opens in new window)
- More
- Click to print (Opens in new window)
- Click to email a link to a friend (Opens in new window)
- Click to share on Telegram (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on Tumblr (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to share on Pocket (Opens in new window)